Injectable contraceptive linked to elevated breast cancer risk

Share this article:
Injectable Contraceptive Linked to Elevated Breast Cancer Risk
Injectable Contraceptive Linked to Elevated Breast Cancer Risk

(HealthDay News) -- Recent use of the injectable contraceptive depo-medroxyprogesterone acetate (DMPA) for 12 months or longer may approximately double the risk of breast cancer in young women, according to a study published online Feb. 27 in Cancer Research.

To investigate the association between DMPA use and breast cancer risk, Christopher I. Li, M.D., Ph.D., from the Fred Hutchinson Cancer Research Center in Seattle, and colleagues conducted a population-based study among 1,028 women aged 20 to 44 years. Structured, in-person questionnaires were completed to obtain information on DMPA use and other relevant covariates.

The researchers observed a 2.2-fold increased risk of invasive breast cancer with recent DMPA use for 12 months or longer. There was little variation in the risk by tumor stage, size, hormone receptor expression, or histological subtype.

"Although breast cancer is rare among young women and the elevated risk of breast cancer associated with DMPA appears to dissipate after discontinuation of use, our findings emphasize the importance of identifying the potential risks associated with specific forms of contraceptives given the number of available alternatives," the authors write.

Abstract
Full Text (subscription or payment may be required)

This article originally appeared here.
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Daily Oncology News

Repeat colonoscopies not always beneficial for some patients

Repeat colonoscopies not always beneficial for some patients

Little benefit seen for repeat colonoscopy within 10 years in patients with no polyps on initial exam.

Adolescent cancer patients risk heavy menstrual bleeding

Adolescent cancer patients risk heavy menstrual bleeding

Oncologist and gynecologist should collaborate to provide appropriate treatment

Lymphoma treatment type affects sperm production

Lymphoma treatment type affects sperm production

Lymphoma treatment type and pretreatment spermatogenesis status are linked to recovery.